HopeStage
Back to all studies
CompletedNCT03008005

Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study

It focuses on PTSD and currently lists study information in the United States.

PTSDDrugFrom 18 Years to 50 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 50 years.

Listed locations
Detroit, United StatesSee all locations and recruitment
Activities
Placebo comparator · Medication described in the protocol
Compensation
Payment and expense reimbursement have not been verified.

Registry last updated: · Record retrieved: . These dates do not confirm site availability.

Study clarity

Study information

Study start dateStarted: June 1, 2017
Recruitment status
Completed
Enrollment listed in the registry
46
Sponsor
Wayne State University
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 50 Years
Official registry ID
NCT03008005
Official title
Effects of THC on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Detroit

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wayne State University, a university.

Did this study involve medication?

Yes. The study involved medication, including Placebo Oral Capsule, Dronabinol Cap 5 milligrams (MG) and Dronabinol Cap 10 milligrams (MG).

Who was this study for?

Listed age limits: 18 years to 50 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me